Evercore ISI is removing Abbott (ABT), Becton Dickinson (BDX), Enovis (ENOV), Stryker (SYK), Illumina (ILMN) and Twist Bioscience (TWST) from the firm’s “Tactical Outperform” list given that the earnings catalysts have passed. The firm still has Mesa Labs (MLAB), which will be reporting in the next three weeks, on the “Tactical Outperform” list, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott Labs EVP of Finance Robert Funck Retires After 36 Years
- Abbott’s dissolving stent receives FDA approval for arteries below the knee
- ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
- 3 Best Healthcare Stocks to Buy in April 2024, According to Analysts
- 3 Best Stocks to Buy Now, 4/23/2024, According to Top Analysts